Switch to
More onapp

ANG Lifesciences India Ltd

ANG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹156 cr, stock is ranked 1,939
High RiskStock is 3.43x as volatile as Nifty
140.156.65 (+4.98%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹156 cr, stock is ranked 1,939
High RiskStock is 3.43x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
3.89
PB RatioPB Ratio
1.87
Dividend YieldDiv. Yield
0.66%
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. The Company’s product portfolio includes antibiotics, antiulcerant, neutraceuticals, anticoagulants, glucocorticoids, anti-inflammatory, antifungal, antihistamines, antimalarial, and anesthetic. Its dosage forms manufactured by Company includes tablets, capsules, oral liquids, liquid injection, prefilled syringe (PFS), dry powder injection and external preparations. The Company’s manufacturing unit is situated at Village Kishan pura, Post office Manpura Baddi Nalagarh Road, Tehsil Nalagarh, District Solan, Himachal Pradesh. The Company manufactures its products in compliance with good manufacturing practices (GMP) requirements.

Investor PresentationView older 

Aug 14, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022121.93127.25154.93355.205.666.096.8540.31
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Board Meeting 
Announced OnOct 8, 2022

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015. | Download

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015. | Download

Cash Dividend 
Ex. DateNov 2, 2021

Interim • Div/Share: ₹ 1

See all events